Reboot Study: TNF & Glucocorticoid Antagonist for GWI Associated Multi-Symptom Disease Hemostasis Reset
Now Recruiting! This dosage finding study will evaluate the safety, effectiveness and biological response to two medications (TNF and Glucocorticoid receptor antagonists) in changing your bodies “sick response” of GWI into a more permanently healthy condition.
For more information, please contact us at 954-262-2870 or email GWICTIC@nova.edu.
Visit ClinicalTrials.gov for study record details.